• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 11/18/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 3:32 PM

    LEXINGTON, MA— XBIO, (Marketwired – February 12, 2016) – Xenetic Biosciences, Inc. (OTCQB: XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics (“Xenetic”) announced today that OPKO Health, Inc. (NYSE: OPK) has acquired an approximate 6.3% interest in Xenetic. Commenting on the investment in Xenetic, Dr. Phillip Frost, CEO and Chairman of OPKO Health, Inc., stated, “Xenetic has many novel technologies that address unmet needs in various orphan cancer indications, and we believe the science

    Read more
  • 3:44 PM

    NEW YORK, Feb. 10, 2016, DCTH, /PRNewswire/ — Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that patient enrollment has begun in the Company’s Phase 3 clinical trial:  “A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma” (the FOCUS Trial). The first patient was evaluated and randomized into

    Read more
  • Dario Logo
    7:02 PM

    – FDA clearance announced on December 22nd – 61% increase in sequential quarterly shipments – Q4 2015 net loss and operating loss narrowed by 9% and 27%, respectively, compared to Q3 2015 – 694% increase in annual shipments – 2015 net loss narrowed by 45% compared to 2014 – Rapid market penetration and favorable user experience PR Newswire, DRIO CAESAREA, Israel, Feb. 9, 2016 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and

    Read more
  • 3:23 PM

    Collaboration With University of Georgia Infectious Disease Researchers Will Speed Development ATLANTA, GA– GOVX, (Marketwired – Feb 3, 2016) – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it has begun a program to develop a vaccine for the prevention of Zika virus infections using its novel MVA-VLP vaccine platform. The company believes that it can rapidly advance a vaccine candidate to human clinical testing. On February 1, 2016, the World Health Organization (WHO)

    Read more
  • 6:19 PM

    Company to Discuss Merger With AEON, Introduce AEON Business and New Senior Management, in Conference Call today at 12 p.m. ET Additional Financial Information can be Found in Form 8-K Filed February 1 BERKELEY HEIGHTS, N.J., Feb. 02, 2016, ADAT, (GLOBE NEWSWIRE) — Authentidate Holding Corp. (Nasdaq:ADAT) today announced AEON’s nine-month 2015 financial results for the period ending September 30, 2015. Authentidate recently completed merger transaction whereby privately-held AEON has merged with a wholly-owned subsidiary of Authentidate, creating a company

    Read more
  • 3:39 PM

    Teams With Leading Investor Relations Firms — Institutional Marketing Services and Wolfe Axelrod Weinberger Associates — to Educate Investment Community on the Company’s Key Business Developments and Compelling Growth Objectives MELBOURNE, FL– FCHS, (Marketwired – Jan 28, 2016) – First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (“FCHS,” “First Choice” or “the Company”), one of the nation’s only non-physician-owned, publicly traded healthcare services companies focused on the delivery of Orthopaedic care and treatment, today announced details relating to its new comprehensive

    Read more
Public Wire Banner